Ethyl acetate extraction from a Chinese herbal formula, Jiedu Xiaozheng Yin, inhibits the proliferation of hepatocellular carcinoma cells via induction of G0/G1 phase arrest in vivo and in vitro

Cao,Zhiyun; Lin,Wei; Huang,Zhengrong; Chen,Xuzheng; Zhao,Jinyan; Zheng,Liangpu; Ye,Hongzhi; Liu,Zhizhen; Liao,Lianming; Du,Jian

doi:10.3892/ijo.2012.1703

Ethyl acetate extraction from a Chinese herbal formula, Jiedu Xiaozheng Yin, inhibits the proliferation of hepatocellular carcinoma cells via induction of G0/G1 phase arrest in vivo and in vitro

Authors:
- Zhiyun Cao
- Wei Lin
- Zhengrong Huang
- Xuzheng Chen
- Jinyan Zhao
- Liangpu Zheng
- Hongzhi Ye
- Zhizhen Liu
- Lianming Liao
- Jian Du
View Affiliations

Affiliations: Fujian Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, P.R. China, Integrated Chinese and Western Medicine Department, Fujian Provincial Cancer Hospital, Fuzhou, P.R. China
Published online on: November 16, 2012 https://doi.org/10.3892/ijo.2012.1703
Pages: 202-210

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Jiedu Xiaozheng Yin (JXY), a polyherbal formula of traditional Chinese medicine (TCM), has been used to treat various kinds of cancer in China. However, the mechanism of its anticancer activity has yet to be elucidated. Air-dried herbs were extracted with reagents of different polarity. HepG2 cells were treated with different doses of ethyl acetate extract (EE-JXY) and chloroform extract (CE-JXY) for 24 h. Cell viability was detected by MTT assay. Colony formation ability was also evaluated. Cell cycle was evaluated by FACS. Tumor bearing BALB/c nude mice was treated with EE-JXY (0.06 g/kg) for 20 days. Tumor volume and weight were monitored. The percentage of PCNA-positive cells and the level of G1 phase proteins [cyclin-dependent kinase2 (CDK2), cyclin‑dependent kinase4 (CDK4), cyclin D and cyclin E and G2 phase proteins [cyclin-dependent kinase1 (CDK1), cyclin A and cyclin B] were detected by immunohistochemistry and western blotting. EE-JXY and CE-JXY dose-dependently inhibited the growth of HepG2 cells (P<0.01 for both). Furthermore, EE-JXY inhibited the formation of cell colonies and blocked the cell cycle to G1 phase in a dose-dependent manner (P<0.01 for all). EE-JXY showed an obviously antitumor effect in vivo (P<0.05). Further investigation showed that EE-JXY decreased the proliferation index of tumors (P<0.01) through increasing the expression of G1-related proteins (cyclin D and cyclin E, P<0.05 and P<0.01). These results suggested that JXY inhibits the growth of HepG2 cells at least via arresting the cell cycle at the G0/G1 phase.

View Figures

View References

1.	Llovet JM, Burroughs A and Bruix J: Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar
2.	Gish RG and Baron A: Hepatocellular carcinoma (HCC): current and evolving therapies. IDrugs. 11:198–203. 2008.PubMed/NCBI
3.	Konkimalla VB and Efferth T: Evidence-based Chinese medicine for cancer therapy. J Ethnopharmacol. 116:207–210. 2008. View Article : Google Scholar : PubMed/NCBI
4.	Beinfield H and Korngold E: Chinese medicine and cancer care. Altern Ther Health Med. 9:38–52. 2003.
5.	Huang CF, Lin SS, Liao PH, Young SC and Yang CC: The immunopharmaceutical effects and mechanisms of herb medicine. Cell Mol Immunol. 5:23–31. 2008. View Article : Google Scholar : PubMed/NCBI
6.	Pan B, Cheng T, Nan KJ, Qiu GQ and Sun XC: Effect of Fuzheng Yiliu decoction combined with chemotherapy on patients with intermediate and late stage gastrointestinal cancer. World J Gastroenterol. 11:439–442. 2005. View Article : Google Scholar : PubMed/NCBI
7.	Yan Y, Cook J, McQuillan J, Zhang G, Hitzman CJ, Wang Y, Wiedmann TS and You M: Chemopreventive effect of aerosolized polyphenon E on lung tumorigenesis in A/J mice. Neoplasia. 9:401–405. 2007. View Article : Google Scholar : PubMed/NCBI
8.	Fang Y, Zhang Y, Chen M, Zheng H and Zhang K: The active component of Hedyotis diffusa Willd. Chinese Trad Plant Med. 26:577–579. 2004.
9.	Wu YG and Song LR: Shanghai Science and Technology Press. Zhong hua ben cao (Chin). 25:530–533. 1998.
10.	Chen XZ, Cao ZY, Chen TS, Zhang YQ, Liu ZZ, Su YT, Liao LM and Du J: Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway. Oncol Rep. 28:742–748. 2012.
11.	Lin J, Chen Y, Wei L, Chen X, Xu W, Hong Z, Sferra TJ and Peng J: Hedyotis Diffusa Willd extract induces apoptosis via activation of the mitochondrion-dependent pathway in human colon carcinoma cells. Int J Oncol. 37:1331–1338. 2010.
12.	Lin J, Wei L, Xu W, Hong Z, Liu X and Peng J: Effect of Hedyotis Diffusa Willd extract on tumor angiogenesis. Mol Med Rep. 4:1283–1288. 2011.
13.	Jitka P, Milan K and Jaromír S: Biological activities of Prunella vulgaris extract. Phytother Res. 17:1082–1087. 2003.
14.	Psotova J, Svobodova A, Kolarova H and Walterova D: Photoprotective properties of Prunella vulgaris and rosmarinic acid on human keratinocytes. J Photochem Photobiol B. 84:167–174. 2006.
15.	Hunter T and Pines J: Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 79:573–582. 1994. View Article : Google Scholar : PubMed/NCBI
16.	Morgan DO: Principles of CDK regulation. Nature. 374:131–134. 1995. View Article : Google Scholar : PubMed/NCBI
17.	Cobrinik D: Pocket proteins and cell cycle control. Oncogene. 24:2796–2809. 2005. View Article : Google Scholar : PubMed/NCBI
18.	Glotzer M: The molecular requirements for cytokinesis. Science. 307:1735–1739. 2005. View Article : Google Scholar : PubMed/NCBI
19.	Tin AS, Sundar SN, Tran KQ, Park AH, Poindexter KM and Firestone GL: Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes. Anticancer Drugs. 23:370–379. 2012. View Article : Google Scholar
20.	Fang XM, Liu B, Liu YB, Wang JJ, Wen JK, Li BH and Han M: Acetylbritannilactone suppresses growth via upregulation of krüppel-like transcription factor 4 expression in HT-29 colorectal cancer cells. Oncol Rep. 26:1181–1187. 2011.PubMed/NCBI
21.	Chen LW, Lin J, Chen W and Zhang W: Effect of Chinese herbal medicine on patients with primary hepatic carcinoma in III stage during perioperational period: a report of 42 cases. Zhongguo Zhong Xi Yi Jie He Za Zhi. 25:832–834. 2005.(In Chinese).
22.	Chen L, Zheng C and Du J: Study on antitumor mechanism of Qingre Xiaozheng drink by molecular docking method. Clin Pharmacol Ther (Chin). 12:324–328. 2007.
23.	Li ZQ: Traditional Chinese medicine for primary liver cancer. World J Gastroenterol. 4:360–364. 1998.
24.	Qui JX and Yang JK: Clinical observation and experimental research in treatment of liver cancer at advanced stage by traditional medication of strengthening the Spleen, replenishing Qi, clearing away heat and toxic material. J Integrated Trad Chin West Med. 7:275–277. 1987.
25.	Yadav SK and Lee SC: Evidence for Oldenlandia diffusa-evoked cancer cell apoptosis through superoxide burst and caspase activation. Zhong Xi Yi Jie He Xue Bao. 4:485–489. 2006.
26.	Rasul A, Yu B, Yang LF, Ali M, Khan M, Ma T and Yang H: Induction of mitochondria-mediated apoptosis in human gastric adenocarcinoma SGC-7901 cells by kuraridin and Nor-kurarinone isolated from Sophora flavescens. Asian Pac J Cancer Prev. 12:2499–2504. 2011.PubMed/NCBI
27.	Lin CC and Namba T: Historical and herbological studies on the traditional Japanese and Chinese crude drugs. On the ‘Shān-cí-gū’. Yakushigaku Zasshi. 20:88–98. 1985.(In Japanese).
28.	Nigg EA: Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays. 17:471–480. 1995. View Article : Google Scholar : PubMed/NCBI
29.	Orlando DA, Lin CY, Bernard A, Wang JY, Socolar JES, Iversen ES, Hartemink AJ and Haase SB: Global control of cell-cycle transcription by coupled CDK and network oscillators. Nature. 453:944–947. 2008. View Article : Google Scholar : PubMed/NCBI
30.	Feng L, Jia XB, Shi F and Chen Y: Identification of two polysaccharides from Prunella vulgaris L and evaluation on their anti-lung adenocarcinoma activity. Molecules. 15:5093–5103. 2010.
31.	Kang SC, Lee CM, Choi H, Lee JH, Oh JS, Kwak JH, Lee JH, Oh JS, Kwak JH and Zee OP: Evaluation of oriental medicinal herbs for estrogenic and antiproliferative activities. Phytother Res. 20:1017–1019. 2006. View Article : Google Scholar : PubMed/NCBI
32.	Zhang Z, Wang X, Wu W, Wang J, Wang Y, Wu X, Fei X, Li S, Zhang J, Dong P, Gu J and Liu Y: Effects of matrine on proliferation and apoptosis in gallbladder carcinoma cells (GBC-SD). Phytother Res. 26:932–937. 2012. View Article : Google Scholar : PubMed/NCBI
33.	Zhang P, Wang Z, Chong T and Ji Z: Matrine inhibits proliferation and induces apoptosis of the androgen-independent prostate cancer cell line PC-3. Mol Med Rep. 5:783–787. 2012.PubMed/NCBI
34.	Qin XG, Hua Z, Shuang W, Wang YH and Cui YD: Effects of matrine on HepG2 cell proliferation and expression of tumor relevant proteins in vitro. Pharm Biol. 48:275–281. 2010. View Article : Google Scholar : PubMed/NCBI
35.	Zhao B, Li B, Bai S, Shen L, Ren R, Jonas JB, Xu X, Lu Q and Liu Q: Effects of matrine on proliferation and apoptosis of cultured retinoblastoma cells. Graefes Arch Clin Exp Ophthalmol. 250:897–905. 2012. View Article : Google Scholar : PubMed/NCBI
36.	Agami R and Bernards R: Convergence of mitogenic and DNA damage signaling in the G1 phase of the cell cycle. Cancer Lett. 177:111–118. 2002. View Article : Google Scholar : PubMed/NCBI
37.	Brew CT, Aronchik I, Hsu JC, Sheen JH, Dickson RB, Bjeldanes LF and Firestone GL: Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells. Int J Cancer. 118:857–868. 2006. View Article : Google Scholar : PubMed/NCBI
38.	Alpan RS and Pardee AB: p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine. Cell Growth Differ. 7:893–901. 1996.PubMed/NCBI